Ipratropium Bromide Inhalation Solution Rx

Select the drug indication to add to your list

Ipratropium Bromide Inhalation Solution

Asthma/COPD
Only 4 drugs may be compared at once

Generic Name and Formulations:

Ipratropium bromide 0.02% (500mcg in 2.5mL); for oral inhalation; preservative-free.

Select therapeutic use:

Indications for Ipratropium Bromide Inhalation Solution:

Bronchospasm associated with chronic bronchitis and emphysema.

Adult:

500mcg orally by nebulization 3–4 times daily; separate doses by 6–8 hours.

Children:

Not established.

Contraindications:

Allergy to atropine or its derivatives.

Warnings/Precautions:

Not for primary treatment of acute attack. Avoid eyes. Narrow-angle glaucoma. GU obstruction. Pregnancy (Cat.B). Nursing mothers.

Interactions:

Caution with other anticholinergics.

See Also:

ATROVENT HFA

Pharmacological Class:

Anticholinergic.

Adverse Reactions:

Bronchitis, COPD exacerbation, dyspnea, headache, anticholinergic effects; paradoxical bronchospasm, hypersensitivity reactions.

Note:

Formerly known under the brand name Atrovent.

Generic Availability:

HFA (NO); soln (YES)

How Supplied:

Inhaler—12.9g (200 inh); inhalation soln—contact supplier